Stock WLLW WILLOW BIOSCIENCES INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Willow Biosciences Inc.

Equities

WLLW

CA97111B4047

End-of-day quote Toronto S.E.
Other stock markets
 23:00:00 30/04/2024 BST 		5-day change 1st Jan Change
0.095 CAD 0.00% Intraday chart for Willow Biosciences Inc. +5.56% -5.00%
04-01 Willow Biosciences Narrows 2023 Loss YOY MT
03-29 Willow Biosciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Willow Biosciences Narrows 2023 Loss YOY
Willow Biosciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Willow Biosciences Inc. Announces Collaboration with Global Active Pharmaceutical Ingredient Manufacturer to Develop A More Sustainable, Cost-Effective Manufacturing Process for A Large Volume Global Market
Willow Biosciences Announces Collaboration with Active Pharmaceutical Ingredient Manufacturer to Manufacture More Sustainable, Cost-Effective Manufacturing Route for Their Largest Product Sold Globally
Willow Biosciences Inc. Announces Collaboration with Enterin, Inc. to Develop Sustainable Interimates and Active Pharmaceutical Ingredients
Willow Biosciences Highlights Growth Plans for 2024, Provides 2023 Highlights
Willow Biosciences prevé que 2024 será un gran año -- Market Talk
Willow Biosciences Reports Q3 Results, Provides Update
Willow Biosciences Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Willow Biosciences Inc. and Suanfarma Announce Collaboration on Development of Large Volume Anti-Infective API Through Precision Fermentation
Willow Biosciences Announced Company Insider Led Convertible Debenture Financing
Willow Biosciences Announced Completion of R&D Program on Cost Effective, Sustainably Produced UDCA
Willow Biosciences Inc. Announces Successful Completion of R&D Program on Covid
Willow Biosciences Inc. Announces Filing of Patent Application for Process to Produce Corticosteroids At Significantly Reduced Cost
Willow Biosciences Inc. Announces Board Changes
Willow Biosciences Inc. Announces Collaboration with Biopharma Company to Develop New Sustainable Manufacturing Routes to Key Intermediates and Active Pharmaceutical Ingredients
Willow Biosciences Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Willow Biosciences Inc. Provides Earnings Guidance for the Year 2023
Kalsec and Willow Biosciences Entry into A Follow-On Master Services Agreement to Develop Novel Enzyme for Production of an Advanced Beverage Ingredient
Willow Biosciences Inc. Announces Executive Changes
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. WLLW Stock
  4. News Willow Biosciences Inc.
  5. Other languages